ArticleClinicoEconomics and outcomes research : CEOR2026
Impact of Delaying Disease Recurrence on Economic Burden in Patients with HER2+ Early-Stage Breast Cancer (eBC).
Nicole Princic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.